(Q44633144)

4 December 2017

title

Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release (English)

1 reference

4 December 2017

1 reference

1 reference

1 reference

8

Andres M Lozano

1 reference

4 December 2017

3

Anthony E Lang

1 reference

4 December 2017

1

Aviva Abosch

1 reference

4 December 2017

2

Shitij Kapur

1 reference

4 December 2017

7

Sylvain Houle

1 reference

4 December 2017

Doug Hussey

4

1 reference

4 December 2017

Elspeth Sime

series ordinal

5

1 reference

4 December 2017

Janis Miyasaki

series ordinal

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

53

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

1095-102; discussion 1102-5

1 reference

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Evidence for striatal dopamine release during a video game.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Parkinson's disease. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Imaging endogenous dopamine competition with [11C]raclopride in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Effects of endogenous dopamine on kinetics of [3H]N-methylspiperone and [3H]raclopride binding in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000088662.69419.1B

10.1227/01.NEU.0000088662.69419.1B

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference